Step 1 topics → Respiratory → Community-Acquired Pneumonia — Typical Organisms

Community-Acquired Pneumonia — Typical Organisms

Community-acquired pneumonia from typical organisms is one of the highest-yield infectious disease topics on USMLE Step 1. The typical organisms — S. pneumoniae, H. influenzae, Moraxella catarrhalis, S. aureus, and Klebsiella — each come with specific clinical clues, radiographic patterns, and sputum findings that the exam exploits heavily. You need to know not just which organism causes CAP, but what the patient looks like, what the chest X-ray shows, and what the sputum tells you. S. pneumoniae dominates: it's the most common typical CAP pathogen across all ages and severity levels, and rust-colored sputum plus lobar consolidation on imaging is its signature presentation.

USMLE Step 1 hits this topic from multiple angles. Pure recall questions ask you to match a pathogen to its clue (currant jelly sputum → Klebsiella in alcoholics; rust sputum + lobar consolidation → S. pneumoniae). Application questions give you a clinical vignette and ask you to pick the antibiotic regimen — which means you need to distinguish outpatient vs. non-ICU inpatient vs. ICU management. Pathology-based questions show you gross or microscopic lung findings and ask you to identify the stage of lobar pneumonia or distinguish lobar from bronchopneumonia patterns.

The tricky parts come from two major confusion zones. First, students mix up the lobar vs. bronchopneumonia association — S. pneumoniae causes lobar, not bronchopneumonia. Second, antibiotic regimen questions trip students up because they conflate severity tiers: the correct regimen for a healthy outpatient is not the same as what an ICU patient needs, and applying fluoroquinolone monotherapy to severe CAP is a classic wrong answer.

From real student decks
81%have cards covering this topic
78%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Gap: Students underestimate Streptococcus pneumoniae as the dominant typical CAP pathogen in all clinical settings
Streptococcus pneumoniae remains the most common cause of typical CAP across all age groups and severity settings.
S. pneumoniae is the #1 typical CAP pathogen across all clinical settings — outpatient, inpatient, and ICU — not just in mild disease. Students often assume its dominance fades in severe cases, but that's wrong. When a Step 1 vignette gives you classic lobar pneumonia without a specific clue steering you elsewhere, S. pneumoniae is the default answer.
Common mistake
Wrong: Bronchopneumonia is caused by Streptococcus pneumoniae and lobar pneumonia by Staphylococcus aureus.
Right: S. pneumoniae classically causes lobar pneumonia; S. aureus and gram-negative rods more often cause bronchopneumonia (patchy, multifocal).
This association is exactly backwards from how many students learn it. S. pneumoniae produces lobar pneumonia — a dense, homogeneous consolidation of an entire lobe that progresses through the classic four pathologic stages. Bronchopneumonia is a patchy, multifocal pattern centered on bronchioles and is more characteristic of S. aureus and gram-negative rods. If a pathology question shows a whole-lobe consolidation, think S. pneumoniae; if it shows scattered peribronchial patches, think S. aureus or gram-negatives.
Common mistake
Wrong: A respiratory fluoroquinolone alone is adequate empiric therapy for ICU-level CAP.
Right: ICU CAP requires combination therapy: a beta-lactam plus either a macrolide or a respiratory fluoroquinolone; monotherapy is insufficient for severe disease.
Fluoroquinolone monotherapy is appropriate for outpatient CAP in patients with comorbidities, but it is never sufficient for ICU-level CAP. Severe CAP requires combination therapy because the additive coverage — particularly for Legionella and other atypicals — improves outcomes. The standard ICU regimen is a beta-lactam (e.g., ceftriaxone) plus either azithromycin or a respiratory fluoroquinolone. Monotherapy in the ICU is a red flag answer on USMLE Step 1.
Common mistake
Wrong: Amoxicillin-clavulanate is the preferred outpatient CAP regimen for healthy patients without comorbidities.
Right: Healthy outpatients without comorbidities are treated with amoxicillin alone or a macrolide; amoxicillin-clavulanate is reserved for patients with comorbidities.
Amoxicillin-clavulanate adds beta-lactamase coverage that healthy outpatients simply don't need. In a young, healthy patient with no comorbidities, amoxicillin alone or a macrolide (azithromycin) is the correct first-line choice. Amoxicillin-clavulanate steps in when the patient has comorbidities like COPD, diabetes, or chronic heart disease, where the pathogen spectrum broadens. Escalating to broader coverage unnecessarily is a management error the exam specifically punishes.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Identify the most likely typical CAP organism based on clinical clues: rust-colored sputum and lobar consolidation point to S. pneumoniae; currant jelly sputum in an alcoholic points to Klebsiella; post-influenza cavitary pneumonia points to S. aureus.
  2. Distinguish lobar pneumonia from bronchopneumonia on pathology: know the four stages of lobar pneumonia (congestion, red hepatization, gray hepatization, resolution) and which organisms classically produce each pattern.
  3. Select the correct outpatient CAP antibiotic regimen based on patient comorbidity status: amoxicillin or macrolide for healthy patients, amoxicillin-clavulanate or respiratory fluoroquinolone for patients with comorbidities.
  4. Construct the correct empiric regimen for ICU-level CAP: combination therapy with a beta-lactam plus a macrolide or respiratory fluoroquinolone is required — monotherapy is never appropriate for severe CAP.

Can you avoid these mistakes?

A 58-year-old alcoholic man presents with high fever, productive cough with thick reddish-brown sputum, and a chest X-ray showing upper lobe consolidation with a bulging fissure sign. What is the most likely organism, and what classic sputum descriptor should you remember for this pathogen?
A pathology slide shows a lung lobe that is firm, airless, and dark red with a liver-like consistency; microscopically there is vascular congestion, edema fluid, and early neutrophil infiltration with intact alveolar architecture. What stage of lobar pneumonia is this, and what organism most commonly produces this pattern?
A 35-year-old previously healthy woman with no comorbidities presents with typical CAP symptoms and is being discharged home. What is the first-line outpatient antibiotic regimen? How does your answer change if she has type 2 diabetes and takes metformin?
A 67-year-old man is admitted to the ICU with severe CAP: he is hypotensive, requiring vasopressors, with a PaO2/FiO2 ratio of 200. The intern recommends levofloxacin monotherapy. Why is this incorrect, and what is the appropriate empiric regimen?

Related topics

Lung Development Stages Surfactant Production and Neonatal RDS Bronchopulmonary Dysplasia Congenital Diaphragmatic Hernia

See how your Anki deck covers this topic.

Upload your deck for a free audit →